IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (39)	9/16/1996 9:03:00 PM
From: I. Luttichuys	of 1762

Good Evening Brad... Just curious about your take on something I've been thinking about. Given that the FDA seems now committed to the "fast-track" approval of HIV related therapeutics I wonder how far they might take this. Any illness which an HIV patient succumbs to is part of the HIV clinical problem. And of course the HIV epidemic is to a large part responsible for the increasing numbers of individuals with NHL, PCP, KS etc. Do you think therapeutics targeted against these others which although not HIV are the result of HIV and potentially fatal might also recieve fast-track handling? Or have you heard any indication from the FDA on such a possibility (at least for the benefit of patients with AIDS)? BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next